ASHLEY PENALOZA: Open Payments
NPI 1669966719 · WINTER HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,719 in 91 payments from 20 companies in 2025. Trend: 2023 $1,845 · 2024 $2,107 · 2025 $1,719
Food & beverage: $1,719
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $299 |
| Amgen Inc. | 18 | $236 |
| GlaxoSmithKline, LLC. | 9 | $155 |
| ABBVIE INC. | 5 | $109 |
| Novartis Pharmaceuticals Corporation | 6 | $105 |
| Phathom Pharmaceuticals, Inc. | 4 | $96 |
| Merck Sharp & Dohme LLC | 5 | $92 |
| Exact Sciences Corporation | 3 | $79 |
| PFIZER INC. | 3 | $74 |
| Novo Nordisk Inc | 3 | $65 |
Products named: OTEZLA, FARXIGA, AIRSUPRA, LEQVIO, VOQUEZNA, VERQUVO, TRELEGY ELLIPTA, VRAYLAR.
Industry payments across FL — which companies pay providers there.
